AI & Software Platforms

Amid soaring demand for skilled labor in Georgia, a new trade school in Decatur offers a fast track to careers in welding, HVAC, and electrical trades.

Lifepoint Health partners with iScribeHealth, deploying ambient AI scribes across its network to reduce documentation and improve patient care.

A 50-year-old facility is set for a massive transformation. See how CIMA+ and partners will build a new athletic, academic, and community hub in Moncton.

Cynomi hires ThreatLocker's former CRO Shane Deegan, signaling a major push to help MSPs turn cybersecurity from a cost center into a profit engine.

A biotech firm's promising concussion therapy, backed by NFL's Alex Smith, shows an 85% responder rate and now seeks public funding for its final push.

Subjective's new partnership with Samba TV uses AI to turn creative briefs into biddable CTV ads, promising a new era of speed and precision for brands.

Following its massive combination with Moss Adams, Baker Tilly names Eric Miles as CEO to steer the $7B firm and redefine service for the middle market.

At CES 2026, an ice cream-scooping robot reveals PaXini's full-stack plan to solve embodied AI's biggest challenges with advanced tactile sensors and data.

The deal merges digital orchestration with field AI, promising pharma a unified, rapid-deployment engagement solution to challenge industry giants.

Dogtopia is equipping dogs with activity monitors in all its daycares, giving owners unprecedented insight into their pet's health and well-being.

Omaha-based Core Bank partners with Kobalt Labs, using AI to slash risk review times from days to minutes and safely accelerate its embedded banking strategy.

Global design firm Populous is evolving, adding real estate strategy to its services to create entire entertainment ecosystems, not just stadiums.

The digital-native waterproof shoe brand Vessi opens its first U.S. store, blending online savvy with a physical footprint and community support.

A new AI receptionist integrated into HawkSoft aims to end missed calls and manual data entry. But are independent agencies ready to trust the technology?

Pharma giant Lilly and AI biotech BigHat are teaming up to solve a critical flaw in AI drug discovery, aiming to unlock a new generation of therapies.

The deal creates an end-to-end commercialization powerhouse, tackling pharma's toughest payer, reimbursement, and patient affordability challenges.

Navan CEO Ariel Cohen will pitch his growth strategy at the Needham conference, a key test for the travel tech firm amid stock declines and high hopes.

A new tri-specific antibody, IM1240, safely hits cancer cells at massive doses in preclinical studies, potentially solving a key toxicity problem in immunotherapy.

A new partnership gives NWS forecasters unprecedented views into weather blind spots, boosting warning capabilities for 130 million Americans.

A new patient app from BrightInsight and Sanofi reduced therapy discontinuation by 4%, proving digital tools can solve medicine's adherence problem.